US Stock MarketDetailed Quotes

LMAT LeMaitre Vascular

Watchlist
  • 81.395
  • -0.485-0.59%
Trading Mar 11 12:07 ET
1.84BMarket Cap42.17P/E (TTM)

About LeMaitre Vascular Company

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Company Profile

SymbolLMAT
Company NameLeMaitre Vascular
Listing DateOct 19, 2006
Issue Price7.00
Founded1983
CEOMr. George W. Lemaitre
MarketNASDAQ
Employees664
Fiscal Year Ends12-31
Address63 Second Avenue
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01803
Phone1-781-221-2266

Company Executives

  • Name
  • Position
  • Salary
  • George W. Lemaitre
  • Chairman of the Board and Chief Executive Officer
  • --
  • Dorian LeBlanc
  • Chief Financial Officer
  • --
  • Chance Kriesel
  • Area Sales Manager, West and Gulf Coast USA
  • --
  • Ina Leininger
  • Regional Sales Manager, Southern Germany and Switzerland
  • --
  • Ryan H. Connelly
  • Senior Vice President, Advanced Manufacturing Engineering
  • --
  • Xiang Zhang
  • Vice President, Regulatory Affairs
  • --
  • Jacob Petersen
  • Senior Vice President, International
  • --
  • Christopher D. Minnett
  • Vice President Sales and Marketing - Americas
  • --
  • Maik D. Helmers
  • Senior Vice President, Sales - Central Europe
  • --
  • James Russell
  • Vice President, Production and Supply Chain
  • --
  • David Hissong
  • Vice President and General Counsel
  • --
  • Helen Goulding
  • Vice President, Sales, Northern Europe
  • --
  • Jonathan W. Ngau
  • Vice President, Information Systems
  • --
  • Andrew Hodgkinson
  • Senior Vice President, Clinical, Regulatory and Quality Affairs
  • --
  • Kimberly L. Cieslak
  • Vice President, Marketing
  • --
  • Giovannella Deiure
  • Vice President, Sales, Southern Europe
  • --
  • Stephane Maier
  • Senior Vice President, Operations - EMEA
  • --
  • Roli Kumar Choudhury
  • Vice President, Quality Affairs
  • --
  • Trent G. Kamke
  • Senior Vice President, Operations
  • 670.38K
  • David B. Roberts
  • Director and President
  • 1.13M
  • Joseph P. Pellegrino,Jr
  • Director
  • 1.07M
  • Jeanwon D. Park
  • Director, Sales - Northeast Asia
  • --
  • Kathryn L. Tebbe
  • Senior Director, Financial Reporting
  • --
  • Daniel J. Mumford
  • Senior Director, Human Resources
  • --
  • Bridget A. Ross
  • Independent Director
  • 144.50K
  • Martha Shadan
  • Independent Director
  • 138.83K
  • Lawrence J. Jasinski
  • Independent Director
  • 153.50K
  • John J. O'Connor
  • Independent Director
  • 163.00K
  • John A. Roush
  • Independent Director
  • 146.50K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.